Oberweis Asset Management »

Arcutis Biotherapeutics shares owned by Oberweis Asset Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Oberweis Asset Management from 13F filings

Historical chart of Oberweis Asset Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Oberweis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Oberweis Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $24M 808k 29.04

More positions owned by Oberweis Asset Management

Lumentum Hldgs (LITE)
Credo Technology Group Holding (CRDO)
Applied Optoelectronics (AAOI)
Sharkninja (SN)
Ambarella (AMBA)
Rambus (RMBS)
SkyWest (SKYW)
Encompass Health Corp (EHC)
Sitime Corp (SITM)
Digitalocean Hldgs (DOCN)
NOVA MEASURING Instruments L (NVMI)
Frontdoor (FTDR)
Brightspring Health Svcs (BTSG)
M/a (MTSI)
Veracyte (VCYT)

View all positions for Oberweis Asset Management

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Polar Capital Holdings
State Street Corporation
Jennison Associates
Vanguard Capital Management
Gilder, Gagnon, Howe & Co
Morgan Stanley
UBS Group
Geode Capital Management
Driehaus Capital Management
D. E. Shaw & Co

View all funds holding Arcutis Biotherapeutics